NINDS is seeking persons with frontotemporal dementia, Pick's disease, progressive aphasia, or corticobasal degeneration, ages 21-80, for an evaluation study involving neuropsychological and genetic testing, a neurological examination, and magnetic resonance imaging (MRI) and positron emission tomography (PET).
Participants should be able to travel to the NIH in Bethesda, MD, for the study and have a diagnosis of one of the following: frontotemporal dementia, Pick's disease, progressive aphasia, or corticobasal degeneration. Persons who are unable to cooperate with neuropsychological testing or unable to travel back and forth to the NIH or who have other serious medical illnesses, may not be eligible.
The study requires a 1- to 2-week inpatient or outpatient stay at the NIH at no cost to the participants. Travel to and from NIH is provided for the participants and caregivers.
For more information, contact Dr. Jordan Grafman, Chief, Cognitive Neuroscience Section, NINDS, at 301-496-0220, or via email at email@example.com. Please refer to study number 81-N-0010.